Vita Longa Probiyotik
Vita longa probiyotik bir saşesindeki 5 farklı suş ve toplam 10 milyar canlı bakteri içerir. Renklendirici, tatlandırıcı, gdo, gluten içermeyen doğal içeriği ile çocuklarda ve yetişkinlerde güvenle kullanılabilir. Birçok hekim ve eczacının çalışmaları sonucu formülüze edilmiş olup, Sakarya Üniversitesi Teknokent işbirliği ile geliştirilmiştir. Çocuklar ve yetişkinler için farklı dozlarda kullanılmak üzere etki gösterir.
KAYNAKLAR
Aggarwal J, Swami G, Kumar M. Probiotics and their Effects on Metabolic Diseases: An Update. J Clin Diagn Res. 2013;7:173-7.1.
Barraud D, Bollaert PE, Gibot S. Impact of the Administration of Probiotics on Mortality in Critically III Adult Patients: A Meta-analysis of Randomized Controlled Trials. Chest. 2013;143:646-55.
Boroni Moreira AP, Fiche Salles Teixeira T, do C Gouveia Peluzio M, de Cassia Gonçalves Alfenas R. Gut microbiota an the development of obesity. Nutr Hosp. 2012;27:1408-14.
Duncan SH, Flint HJ. Probiotics and prebiotics and health in ageing populations. Maturitas. 2013 Mar 11. Pii: S0378-5122(13)00019-2.
Hamad A, Fragkos KC, Forbes A. A systematic and meta-analysis of probiotics for the menangement of radiation induced bowel disease. İn Nutr. 2013 Feb 18. Pii:S0261-5614(13)00050-2.
Hardy H, Harris J, Lyon E, Beal J, Foey AD. Probiotics, prebiotics and immunomodilation of gut mucosal defences: homeostasis and immunopathology. Nutrients. 2013;5:1869-912.
Hijova E, Soltesova A. Effects of probiotics and prebiotics in ulcerative colitis. Bratisl Lek Listy. 2013;114:540-3.
Horvath A, Szajewska H. Probiotics, prebiotics and dietary fiber in the management of functional gastrointestinal disorders. World Rev Nutr Diet. 2013;108-40-8.
Jirillo E, Jirillo F, Magrone T. Healthy effects exerted by prebiotics, probiotics and symbiotics with special reference to their impact on the immune system. Int J Vitam Nutr Res. 2012;82:200-8
Parker MW, Schaffzin JK, Lo Vecchio A ve ark. Rapid Adaption of Lactobacillus rhamnosus GG for acute gastroenteritis. Pediatrics. 2013;131 S1:S96-s102.
Roberts LM, McCahon D, Holder R, Wilson S, Hobbs FR. A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome. BMC Gastroenterol. 2013;13:45.
Turroni F, Ventura M, Butto LF ve ark. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci. 2013 Mar 21. (Epub ahead of print)
Weichert S, Schroten H, Adam R. The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases. Pediatr Infect Dis J. 2012;31:859-62
Lucio Capurso, Thirty Years of Lactobacillus rhamnosus GG: A Review.J Clin Gastroenterol. 2019 Mar;53 Suppl 1:S1-S41.
Joanna Jerzynska 1, Wlodzimierz Stelmach, Joanna Balcerak, Katarzyna Woicka-Kolejwa, Blazej Rychlik, Andrzej Blauz, Marcin Wachulec, Piotr Stelmach, Pawel Majak, Iwona Stelmach Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy, Allergy Asthma Proc. 2016 Jul;37(4):324-34.
Vicente Navarro-López , Ana Ramírez-Boscá , Daniel Ramón-Vidal , Beatriz Ruzafa-Costas , Salvador Genovés-Martínez , Empar Chenoll-Cuadros , Miguel Carrión-Gutiérrez , José Horga de la Parte , David Prieto-Merino , Francisco M Codoñer-Cortés, Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial JAMA Dermatol. 2018 Jan 1;154(1):37-43.
Merve Usta, Nafiye Urgancı. Probiotic Use in Childhood,Review. The Journal of Current Pediatrics. 2014;2:88-94.
Kau AL, Ahern PP, Grifin NW, Goodman AL, Gordon JI. Human Nutrition, the gut microbiome and immune system. Nature 2011;474:327-36
Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004;4:478-85.
Çokuğraş FÇ, Beşer ÖF. Mukozal immünite. Turkiye Klinikleri J Pediatr Sci 2012;8:19-26.
Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011;45:149-53.
Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001;138:361-5.
Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhea. Cochrane Satabase Syst Rev 2010;10:CD003048.
Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, doubleblind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001;33:17-25.
Chen CC, Khon MS, Lai MW, Chao HC, Chang KW, Chen SY, et al. Probiotics have clinical, microbiologic and immunologic efficacy in acute infectious diarrhea. Pediatr Infec Dis J 2010;29:135-8.
D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1361.
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011;CD004827.
Uysal P, Uzuner N. Allerjik hastalıklar ve Probiyotikler. Turkiye Klinikleri J Pediatr Sci 2012;8:57-66.
Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005;90:892-7.
Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007;CD006135.
Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML. Probiotics for treating eczema. Cochrane Database Syst Rev 2008;CD006135.
Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007;137:812-18.
Sıkora J, Valeckova K, Amlerova J, Siala K, Dedek P, Watkins S, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005;39:692-8.
Demirören K, Özen H. İnflamatuar Bağırsak Hastalıklarının Tedavisinde Probiyotikler. Turkiye Klinikleri J Pediatr Sci 2012;8:34-42.
Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007;CD005573.
. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009;104:437-43.
Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm Bowel Dis 2005;11:833-9.
Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2006;CD004826.
Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005;147:197-201.
Aksu AU, Dalgıc B. İrritabl Bağırsak hastalığı ve probiyotikler. Turkiye Klinikleri J Pediatr Sci 2012;8:43-7.
Banaszkiewicz A, Szajewska H. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo controlled randomized trial. J Pediatr 2005;146:364-9.
Arslan N. Obezite ve probiyotikler. Turkiye Klinikleri J Pediatr Sci 2012;8:102-9.